LD-2 disclosure · 4th Quarter - Report
SHIRE PHARMACEUTICALS LLC
Client
- Location
- District of Columbia · United States of America
Registrant
- Description
- Pharmaceutical Company
- Location
- Washington, District of Columbia, United States of America
Lobbying activities
4 issuesMedicare/Medicaid
- Home Infusion technical change to H.R.6 21st Century Cures to move wrap around training and monitoring services benefit forward from 2021 to 2018 implementation. - Medicare coverage and reimbursement - Medicare Part B drug payment model demonstration - Affordable Care Act Medicaid Expansion - Medicare IVIG Access Act Reauthorization HR 3172 - Medicare Part D
LobbyistsENGEL BURNS · JED PERRY
TargetedSENATE · HOUSE OF REPRESENTATIVES
Taxation/Internal Revenue Code
Orphan drug tax credit HR 1: An Act to provide for reconciliation pursuant to titles II and V of the concurrent resolution on the budget for fiscal year 2018 (Tax Cuts and Jobs Act)
LobbyistsMARK LENKER · JED PERRY
TargetedSENATE · HOUSE OF REPRESENTATIVES
Health Issues
340B Drug Discount Program Orphan Drug Act Gene Therapy Drug Pricing
LobbyistsMARK LENKER · ENGEL BURNS · JED PERRY
TargetedSENATE · HOUSE OF REPRESENTATIVES